{"transactions":[{"id":747045,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-06-08T20:01:07.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":false,"shares":13043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on June 5, 2025, with 13,043 vested on June 5, 2026, 13,043 vesting on each of June 5, 2027 and June 5, 2028, and 13,044 vesting on June 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on June 5, 2025, with 13,043 vested on June 5, 2026, 13,043 vesting on each of June 5, 2027 and June 5, 2028, and 13,044 vesting on June 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":39130,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13043},"source":{"system":"sec-edgar","filing":"0001193125-26-261660","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261660/ownership.xml","form_type":"4"}},{"id":747044,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:01:07.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":6153,"price":34.35,"value":211355.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."}],"balance_after":1177529,"source":{"system":"sec-edgar","filing":"0001193125-26-261660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261660/ownership.xml","form_type":"4"}},{"id":747043,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-06-08T20:01:07.000Z","date":"2026-06-05","kind":"exercise","planned":true,"acquired":true,"shares":13043,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1183682,"source":{"system":"sec-edgar","filing":"0001193125-26-261660","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526261660/ownership.xml","form_type":"4"}},{"id":854925,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:18:05.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":42452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 42,452 vested on March 5, 2026, 42,452 vesting on each of March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 42,452 vested on March 5, 2026, 42,452 vesting on each of March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":127359,"derivative":{"underlying":"Ordinary Shares","underlying_shares":42452},"source":{"system":"sec-edgar","filing":"0001193125-26-098551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098551/ownership.xml","form_type":"4"}},{"id":854924,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:18:05.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":20025,"price":31.6684,"value":634159.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1170639,"source":{"system":"sec-edgar","filing":"0001193125-26-098551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098551/ownership.xml","form_type":"4"}},{"id":854923,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:18:05.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":42452,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1190664,"source":{"system":"sec-edgar","filing":"0001193125-26-098551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098551/ownership.xml","form_type":"4"}},{"id":857169,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"grant","planned":true,"acquired":true,"shares":136736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 34,184 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2026, with 34,184 vesting on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":136736,"derivative":{"underlying":"Ordinary Shares","underlying_shares":136736},"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857168,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":50223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 50,223 vested on each of March 4, 2025 and March 4, 2026, and 50,223 vesting on each of March 4, 2027 and March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2024, with 50,223 vested on each of March 4, 2025 and March 4, 2026, and 50,223 vesting on each of March 4, 2027 and March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":100446,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50223},"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857167,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":23393,"price":32.4645,"value":759442.0485,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.095 to $33.30, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1148212,"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":857166,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:19:36.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":50223,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1171605,"source":{"system":"sec-edgar","filing":"0001193125-26-096591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096591/ownership.xml","form_type":"4"}},{"id":859914,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:05:09.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":891315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on March 3, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":891315},"source":{"system":"sec-edgar","filing":"0001193125-26-093916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093916/ownership.xml","form_type":"4"}},{"id":859913,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-03-05T21:05:09.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":67231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 67,231 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 67,231 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 67,231 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 67,231 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":67231,"derivative":{"underlying":"Ordinary Shares","underlying_shares":67231},"source":{"system":"sec-edgar","filing":"0001193125-26-093916","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093916/ownership.xml","form_type":"4"}},{"id":859912,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:05:09.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":412032,"price":32.3599,"value":13333314.3168,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1121382,"source":{"system":"sec-edgar","filing":"0001193125-26-093916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093916/ownership.xml","form_type":"4"}},{"id":859911,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:05:09.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":891315,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":1533414,"source":{"system":"sec-edgar","filing":"0001193125-26-093916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093916/ownership.xml","form_type":"4"}},{"id":859910,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:05:09.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":30903,"price":32.3599,"value":1000017.9897,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":642099,"source":{"system":"sec-edgar","filing":"0001193125-26-093916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093916/ownership.xml","form_type":"4"}},{"id":859909,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-05T21:05:09.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":67231,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":673002,"source":{"system":"sec-edgar","filing":"0001193125-26-093916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526093916/ownership.xml","form_type":"4"}},{"id":898939,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-02-18T21:01:11.000Z","date":"2026-02-15","kind":"exercise","planned":true,"acquired":false,"shares":620110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on February 15, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on February 15, 2026, following satisfaction of the time-based vesting criteria."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":620110},"source":{"system":"sec-edgar","filing":"0001193125-26-056996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526056996/ownership.xml","form_type":"4"}},{"id":898938,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-02-18T21:01:11.000Z","date":"2026-02-15","kind":"exercise","planned":true,"acquired":false,"shares":161656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 15, 2023, with 161,655 vested on each of February 15, 2024 and February 15, 2025, and 161,656 vested on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 15, 2023, with 161,655 vested on each of February 15, 2024 and February 15, 2025, and 161,656 vested on February 15, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":161656},"source":{"system":"sec-edgar","filing":"0001193125-26-056996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526056996/ownership.xml","form_type":"4"}},{"id":898937,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-02-18T21:01:11.000Z","date":"2026-02-15","kind":"sale","planned":true,"acquired":false,"shares":286122,"price":34.2241,"value":9792267.9402,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents (1) with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting, and (2) with respect to the restricted share units granted subject to performance criteria, the reporting person sold such number of shares required to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.015 to $34.51, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":605771,"source":{"system":"sec-edgar","filing":"0001193125-26-056996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526056996/ownership.xml","form_type":"4"}},{"id":898936,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-02-18T21:01:11.000Z","date":"2026-02-15","kind":"exercise","planned":true,"acquired":true,"shares":620110,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":891893,"source":{"system":"sec-edgar","filing":"0001193125-26-056996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526056996/ownership.xml","form_type":"4"}},{"id":898935,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-02-18T21:01:11.000Z","date":"2026-02-15","kind":"sale","planned":true,"acquired":false,"shares":161656,"price":34.2241,"value":5532531.1096,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents (1) with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting, and (2) with respect to the restricted share units granted subject to performance criteria, the reporting person sold such number of shares required to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.015 to $34.51, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":271783,"source":{"system":"sec-edgar","filing":"0001193125-26-056996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526056996/ownership.xml","form_type":"4"}},{"id":898934,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-02-18T21:01:11.000Z","date":"2026-02-15","kind":"exercise","planned":true,"acquired":true,"shares":161656,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":433439,"source":{"system":"sec-edgar","filing":"0001193125-26-056996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526056996/ownership.xml","form_type":"4"}},{"id":928297,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-01-29T21:01:12.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":891315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 3, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":891315,"derivative":{"underlying":"Ordinary Shares","underlying_shares":891315},"source":{"system":"sec-edgar","filing":"0001193125-26-029300","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526029300/ownership.xml","form_type":"4"}},{"id":928296,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2026-01-29T21:01:12.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":620110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted shares units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted shares units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 15, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":620110,"derivative":{"underlying":"Ordinary Shares","underlying_shares":620110},"source":{"system":"sec-edgar","filing":"0001193125-26-029300","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526029300/ownership.xml","form_type":"4"}},{"id":1118873,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-06-09T20:01:33.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":52173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on June 5, 2025, with 13,043 vesting on each of June 5, 2026, June 5, 2027, and June 5, 2028 and 13,044 vesting on June 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on June 5, 2025, with 13,043 vesting on each of June 5, 2026, June 5, 2027, and June 5, 2028 and 13,044 vesting on June 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":52173,"derivative":{"underlying":"Ordinary Shares","underlying_shares":52173},"source":{"system":"sec-edgar","filing":"0000950170-25-083680","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025083680/ownership.xml","form_type":"4"}},{"id":1218502,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-03-07T21:02:32.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":169811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 42,452 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 42,452 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 42,455 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":169811,"derivative":{"underlying":"Ordinary Shares","underlying_shares":169811},"source":{"system":"sec-edgar","filing":"0000950170-25-035467","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035467/ownership.xml","form_type":"4"}},{"id":1220793,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-03-06T21:03:17.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":false,"shares":50223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 50,223 vested on March 4, 2025, and 50,223 vesting on each of March 4, 2026, March 4, 2027 and March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 50,223 vested on March 4, 2025, and 50,223 vesting on each of March 4, 2026, March 4, 2027 and March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":150669,"derivative":{"underlying":"Ordinary Shares","underlying_shares":50223},"source":{"system":"sec-edgar","filing":"0000950170-25-034583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034583/ownership.xml","form_type":"4"}},{"id":1220792,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:03:17.000Z","date":"2025-03-05","kind":"sale","planned":true,"acquired":false,"shares":8259,"price":15.9132,"value":131427.1188,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.68 to $16.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":271783,"source":{"system":"sec-edgar","filing":"0000950170-25-034583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034583/ownership.xml","form_type":"4"}},{"id":1220791,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:03:17.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":15514,"price":15.7346,"value":244106.5844,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.28 to $16.015, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":280042,"source":{"system":"sec-edgar","filing":"0000950170-25-034583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034583/ownership.xml","form_type":"4"}},{"id":1220790,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-06T21:03:17.000Z","date":"2025-03-04","kind":"exercise","planned":true,"acquired":true,"shares":50223,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":295556,"source":{"system":"sec-edgar","filing":"0000950170-25-034583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025034583/ownership.xml","form_type":"4"}},{"id":1224651,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-03-05T21:04:45.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":67231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 3, 2023, with 67,231 vested on each of March 3, 2024 and March 3, 2025, and 67,231 vesting on each of March 3, 2026 and March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 3, 2023, with 67,231 vested on each of March 3, 2024 and March 3, 2025, and 67,231 vesting on each of March 3, 2026 and March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":134462,"derivative":{"underlying":"Ordinary Shares","underlying_shares":67231},"source":{"system":"sec-edgar","filing":"0000950170-25-033515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033515/ownership.xml","form_type":"4"}},{"id":1224650,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:04:45.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":6450,"price":15.5576,"value":100346.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.455 to $15.75, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":245333,"source":{"system":"sec-edgar","filing":"0000950170-25-033515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033515/ownership.xml","form_type":"4"}},{"id":1224649,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:04:45.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":24892,"price":16.1855,"value":402889.466,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.86 to $16.53, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":251783,"source":{"system":"sec-edgar","filing":"0000950170-25-033515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033515/ownership.xml","form_type":"4"}},{"id":1224648,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-05T21:04:45.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":67231,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":276675,"source":{"system":"sec-edgar","filing":"0000950170-25-033515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025033515/ownership.xml","form_type":"4"}},{"id":1262210,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2025-02-19T21:03:13.000Z","date":"2025-02-15","kind":"exercise","planned":true,"acquired":false,"shares":161655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 15, 2023 with 161,655 vested on each of February 15, 2024 and February 15, 2025, and 161,656 vesting on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 15, 2023 with 161,655 vested on each of February 15, 2024 and February 15, 2025, and 161,656 vesting on February 15, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":161656,"derivative":{"underlying":"Ordinary Shares","underlying_shares":161655},"source":{"system":"sec-edgar","filing":"0000950170-25-023126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025023126/ownership.xml","form_type":"4"}},{"id":1262209,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-02-19T21:03:13.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":75506,"price":16.9478,"value":1279660.5868,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.885 to $17.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":209444,"source":{"system":"sec-edgar","filing":"0000950170-25-023126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025023126/ownership.xml","form_type":"4"}},{"id":1262208,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2025-02-19T21:03:13.000Z","date":"2025-02-15","kind":"exercise","planned":true,"acquired":true,"shares":161655,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":284950,"source":{"system":"sec-edgar","filing":"0000950170-25-023126","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025023126/ownership.xml","form_type":"4"}},{"id":1365472,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-14T18:35:57.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":182,"derivative":{"exercise_price":1260.97,"exercise_date":"2025-11-12","expiration_date":"2034-11-12","underlying":"Common Stock, par value $0.01 per share","underlying_shares":182},"source":{"system":"sec-edgar","filing":"0001062993-24-019115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299324019115/form4.xml","form_type":"4"}},{"id":1365471,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2024-11-14T18:35:57.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":71,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":624,"source":{"system":"sec-edgar","filing":"0001062993-24-019115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299324019115/form4.xml","form_type":"4"}},{"id":1600201,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:27:46.000Z","date":"2024-03-04","kind":"grant","planned":true,"acquired":true,"shares":200892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 50,223 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027 and March 4, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 4, 2024, with 50,223 vesting on each of March 4, 2025, March 4, 2026, March 4, 2027 and March 4, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":200892,"derivative":{"underlying":"Ordinary Shares","underlying_shares":200892},"source":{"system":"sec-edgar","filing":"0000950170-24-026008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026008/ownership.xml","form_type":"4"}},{"id":1600200,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2024-03-05T21:27:46.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":false,"shares":67231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 67,231 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 3, 2023, with 67,231 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":201693,"derivative":{"underlying":"Ordinary Shares","underlying_shares":67231},"source":{"system":"sec-edgar","filing":"0000950170-24-026008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026008/ownership.xml","form_type":"4"}},{"id":1600199,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:27:46.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":31061,"price":13.3373,"value":414269.8753,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.445, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":123295,"source":{"system":"sec-edgar","filing":"0000950170-24-026008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026008/ownership.xml","form_type":"4"}},{"id":1600198,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-03-05T21:27:46.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":true,"shares":67231,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":154356,"source":{"system":"sec-edgar","filing":"0000950170-24-026008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024026008/ownership.xml","form_type":"4"}},{"id":1636157,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2024-02-20T12:42:23.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":false,"shares":161655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 15, 2023, with 161,655 vesting on each of February 15, 2024 and February 15, 2025, and 161,656 vesting on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 15, 2023, with 161,655 vesting on each of February 15, 2024 and February 15, 2025, and 161,656 vesting on February 15, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":323311,"derivative":{"underlying":"Ordinary Shares","underlying_shares":161655},"source":{"system":"sec-edgar","filing":"0000950170-24-016803","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024016803/ownership.xml","form_type":"4"}},{"id":1636156,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-02-20T12:42:23.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":74530,"price":13.1514,"value":980173.842,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.09 to $13.24, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":87125,"source":{"system":"sec-edgar","filing":"0000950170-24-016803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024016803/ownership.xml","form_type":"4"}},{"id":1636155,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2024-02-20T12:42:23.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":true,"shares":161655,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":161655,"source":{"system":"sec-edgar","filing":"0000950170-24-016803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024016803/ownership.xml","form_type":"4"}},{"id":1744439,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-11-13T13:45:19.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":250,"derivative":{"exercise_price":1024.55,"exercise_date":"2024-11-09","expiration_date":"2033-11-09","underlying":"Common Stock, par value $0.01 per share","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001062993-23-020526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299323020526/form4.xml","form_type":"4"}},{"id":1744438,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2023-11-13T13:45:19.000Z","date":"2023-11-09","kind":"grant","planned":false,"acquired":true,"shares":49,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":553,"source":{"system":"sec-edgar","filing":"0001062993-23-020526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299323020526/form4.xml","form_type":"4"}},{"id":1967226,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2023-03-07T21:06:05.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":268924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 3, 2023, with 67,231 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 3, 2023, with 67,231 vesting on each of March 3, 2024, March 3, 2025, March 3, 2026, and March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":268924,"derivative":{"underlying":"Ordinary Shares","underlying_shares":268924},"source":{"system":"sec-edgar","filing":"0001209191-23-016701","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123016701/doc4.xml","form_type":"4"}},{"id":2009512,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Share Units","published_at":"2023-02-17T12:03:39.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":484966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 15, 2023, with 161,655 vesting on each of February 15, 2024 and February 15, 2025, and 161,656 vesting on February 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 15, 2023, with 161,655 vesting on each of February 15, 2024 and February 15, 2025, and 161,656 vesting on February 15, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":484966,"derivative":{"underlying":"Ordinary Shares","underlying_shares":484966},"source":{"system":"sec-edgar","filing":"0001209191-23-010333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000120919123010333/doc4.xml","form_type":"4"}},{"id":2123626,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-07T15:43:55.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":224,"derivative":{"exercise_price":1225.87,"exercise_date":"2023-11-03","expiration_date":"2032-11-03","underlying":"Common Stock, par value $0.01 per share","underlying_shares":224},"source":{"system":"sec-edgar","filing":"0001062993-22-021603","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299322021603/form4.xml","form_type":"4"}},{"id":2123625,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2022-11-07T15:43:55.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":41,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":504,"source":{"system":"sec-edgar","filing":"0001062993-22-021603","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299322021603/form4.xml","form_type":"4"}},{"id":2521751,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-08T14:47:07.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":222,"derivative":{"exercise_price":1484.4,"exercise_date":"2022-11-04","expiration_date":"2031-11-04","underlying":"Common Stock, par value $0.01 per share","underlying_shares":222},"source":{"system":"sec-edgar","filing":"0001062993-21-010347","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299321010347/form4.xml","form_type":"4"}},{"id":2521750,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2021-11-08T14:47:07.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":30,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":463,"source":{"system":"sec-edgar","filing":"0001062993-21-010347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000106299321010347/form4.xml","form_type":"4"}},{"id":2988493,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-09T19:25:25.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":316,"derivative":{"exercise_price":1103.74,"exercise_date":"2021-11-05","expiration_date":"2030-11-05","underlying":"Common stock, par value $0.01 per share","underlying_shares":316},"source":{"system":"sec-edgar","filing":"0001515622-20-000045","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562220000045/edgar.xml","form_type":"4"}},{"id":2988492,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2020-11-09T19:25:25.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":41,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":433,"source":{"system":"sec-edgar","filing":"0001515622-20-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562220000045/edgar.xml","form_type":"4"}},{"id":3374966,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-12T15:22:15.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":458,"derivative":{"exercise_price":720.81,"exercise_date":"2020-11-07","expiration_date":"2029-11-07","underlying":"Common stock, par value $0.01 per share","underlying_shares":458},"source":{"system":"sec-edgar","filing":"0001515622-19-000047","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562219000047/edgar.xml","form_type":"4"}},{"id":3374965,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2019-11-12T15:22:15.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":62,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":392,"source":{"system":"sec-edgar","filing":"0001515622-19-000047","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562219000047/edgar.xml","form_type":"4"}},{"id":3768295,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-13T15:26:13.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":474,"derivative":{"exercise_price":595.31,"exercise_date":"2019-11-08","expiration_date":"2028-11-08","underlying":"Common stock, par value $0.01 per share","underlying_shares":474},"source":{"system":"sec-edgar","filing":"0001515622-18-000043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562218000043/edgar.xml","form_type":"4"}},{"id":3768294,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2018-11-13T15:26:13.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":76,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":330,"source":{"system":"sec-edgar","filing":"0001515622-18-000043","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562218000043/edgar.xml","form_type":"4"}},{"id":4151806,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-11-24T18:21:39.000Z","date":"2017-11-17","kind":"purchase","acquired":true,"shares":160,"price":627.91,"value":100465.6,"ownership":{"direct":true},"balance_after":254,"source":{"system":"sec-edgar","filing":"0001515622-17-000088","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562217000088/edgar.xml","form_type":"4"}},{"id":4171621,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-11-06T15:08:13.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":476,"derivative":{"exercise_price":671.6,"exercise_date":"2018-11-02","expiration_date":"2027-11-02","underlying":"Common stock, par value $0.01 per share","underlying_shares":476},"source":{"system":"sec-edgar","filing":"0001515622-17-000069","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562217000069/edgar.xml","form_type":"4"}},{"id":4171620,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2017-11-06T15:08:13.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":94,"source":{"system":"sec-edgar","filing":"0001515622-17-000069","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562217000069/edgar.xml","form_type":"4"}},{"id":4565687,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-11-07T18:24:10.000Z","date":"2016-11-03","kind":"grant","acquired":true,"shares":832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest annually in two equal installments beginning on the first anniversary of the date of grant."}],"balance_after":832,"derivative":{"exercise_price":397.95,"exercise_date":"2017-11-03","expiration_date":"2026-11-03","underlying":"Common stock, par value $0.01 per share","underlying_shares":832},"source":{"system":"sec-edgar","filing":"0001515622-16-000116","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562216000116/edgar.xml","form_type":"4"}},{"id":4565686,"issuer":{"id":3168,"kind":"organization","name":"METTLER TOLEDO INTERNATIONAL INC/"},"owners":[{"id":40715,"kind":"person","name":"Francis Richard D","position":1,"cik":"0001673277","reported_name":"Francis Richard D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01 per share","published_at":"2016-11-07T18:24:10.000Z","date":"2016-11-03","kind":"grant","acquired":true,"shares":59,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":59,"source":{"system":"sec-edgar","filing":"0001515622-16-000116","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037646/000151562216000116/edgar.xml","form_type":"4"}}]}